|
J Biol Chem, Vol. 275, Issue 4, 2745-2755, January 28, 2000
A Developmentally Regulated Aconitase Related to
Iron-regulatory Protein-1 Is Localized in the Cytoplasm and in the
Mitochondrion of Trypanosoma brucei*
Joachim
Saas §,
Karl
Ziegelbauer¶ ,
Arndt
von
Haeseler**,
Beate
Fast §, and
Michael
Boshart §
From the Arbeitsgruppe Molekulare Zellbiologie,
Institut für Molekularbiologie und Biochemie und Institut
für Infektionsmedizin, Freie Universität, Berlin, the
§ Max-Planck-Institut für Biochemie, Martinsried, the
¶ Max-Planck-Institut für Biologie, Tübingen, and the
** Max-Planck-Institut für Evolutionäre Anthropologie,
Leipzig, Germany
 |
ABSTRACT |
Mitochondrial energy metabolism and Krebs cycle
activities are developmentally regulated in the life cycle of the
protozoan parasite Trypanosoma brucei. Here we report
cloning of a T. brucei aconitase gene that is closely
related to mammalian iron-regulatory protein 1 (IRP-1) and plant
aconitases. Kinetic analysis of purified recombinant TbACO expressed in
Escherichia coli resulted in a Km
(isocitrate) of 3 ± 0.4 mM, similar to aconitases of
other organisms. This was unexpected since an arginine conserved in the
aconitase protein family and crucial for substrate positioning in the
catalytic center and for activity of pig mitochondrial aconitase
(Zheng, L., Kennedy, M. C., Beinert, H., and Zalkin, H. (1992)
J. Biol. Chem. 267, 7895-7903) is substituted by
leucine in the TbACO sequence. Expression of the 98-kDa TbACO was shown to be lowest in the slender bloodstream stage of the parasite, 8-fold
elevated in the stumpy stage, and increased a further 4-fold in the
procyclic stage. The differential expression of TbACO protein contrasted with only minor changes in TbACO mRNA,
indicating translational or post-translational mechanisms of
regulation. Whereas animal cells express two distinct compartmentalized
aconitases, mitochondrial aconitase and cytoplasmic aconitase/IRP-1,
TbACO accounts for total aconitase activity in trypanosomes. By cell
fractionation and immunofluorescence microscopy, we show that native as
well as a transfected epitope-tagged TbACO localizes in both the
mitochondrion (30%) and in the cytoplasm (70%). Together with
phylogenetic reconstructions of the aconitase family, this suggests
that animal IRPs have evolved from a multicompartmentalized ancestral
aconitase. The possible functions of a cytoplasmic aconitase in
trypanosomes are discussed.
 |
INTRODUCTION |
Trypanosoma brucei is a protozoan parasite in the blood
and tissue fluids of mammals and causes two major tropical diseases, sleeping sickness in man and nagana in cattle. The flagellate is
transmitted in subsaharan Africa between humans, livestock, and a huge
reservoir of game animals by the tsetse fly, a bloodsucking insect
vector. During cyclical transmission between mammals and tsetse,
trypanosomes differentiate into a series of life cycle stages with
distinct morphology, metabolism, and surface proteins to cope with the
changing host environments and host defense mechanisms (1). The
proliferating forms in the host blood have elongated and slender
appearance (long slender forms) and rely entirely on glycolysis for
energy production (2-4). Inefficient substrate utilization seems
affordable at that developmental stage, due to glucose homeostasis in
host blood. Hence, slender forms lack significant amounts of Krebs
cycle enzymes (5), and their residual mitochondrion does not contribute
to ATP production. At the peak of a parasitemic wave, slender forms
differentiate into a quiescent, cell cycle-arrested stage with stumpy
morphology (stumpy form) which has a more developed mitochondrion and
expresses citric acid cycle activities and an incomplete electron
transport chain (5-8). In culture, differentiation to the stumpy
stage is induced by a cell density sensing mechanism acting via the
cAMP second messenger pathway (9, 10). A population of stumpy forms, in
turn, can be triggered to differentiate rapidly and synchronously to
the next stage in the life cycle, the procyclic forms, which populate
the fly midgut and rely on respiration of proline as their major energy
source. Therefore, induction of Krebs cycle enzymes and of a
respiratory chain in stumpy forms is regarded as a preadaptation to the
fly environment (8). The signal for differentiation to procyclic forms
in the midgut of the tsetse is unknown; however, the process can be
triggered in culture by a temperature shift to 27 °C or most
efficiently by addition of cis-aconitate or citrate to the
culture medium (11, 12). The differentiation inducing effect of
cis-aconitate and citrate is highly specific. The peculiar
role of these substrates in triggering a developmental switch and the
coordinate induction of the citric acid cycle enzymes during
differentiation to the stumpy stage prompted us to identify and
characterize the aconitase gene of T. brucei.
Aconitase (citrate(isocitrate) hydro-lyase, EC 4.2.1.3) catalyzes the
stereospecific dehydration/rehydration reaction of citrate to
isocitrate via the intermediate cis-aconitate (13). Activity
of the enzyme critically depends on the presence of an iron sulfur
[4Fe4S] cluster in the catalytic center that is highly sensitive to
oxygen. Upon oxidation the cluster is converted to an inactive
[3Fe4S] form (14). Mammalian cells express two distinct aconitases
encoded by separate genes: (a) mitochondrial aconitase and
(b) a bifunctional cytoplasmic aconitase that is identical to the iron-regulatory protein
(IRP-1).1 IRP-1 is an
RNA-binding protein interacting with iron-responsive elements (IREs) in
the untranslated regions of several mRNAs (15), including the
transferrin receptor and ferritin H- and L-subunits (16), and functions
in coordinate post-transcriptional regulation of cellular iron
metabolism (17, 18). In iron-loaded cells, IRP-1 assembles a cubane
[4Fe-4S] cluster, which renders it active as a cytosolic aconitase
but inactive for RNA binding. Disassembly of the cluster upon iron
starvation yields the active RNA-binding form that regulates stability
or translation of target RNAs. The two conformations and functional
states are mutually exclusive. Cytoplasmic aconitase activity might
also be required for a glyoxalate cycle in specialized animal tissues
like brown adipose tissue (19). In plants, where cytoplasmic aconitase
is developmentally regulated and abundant in germinating seeds, its
role in the glyoxalate cycle is well established (20, 21).
Here we report on cloning and characterization of a protozoan aconitase
that is closely related to animal IRPs and plant aconitases. Dual
subcellular localization of the developmentally regulated T. brucei enzyme suggests that it not only takes part in the
mitochondrial Krebs cycle but may have a yet unknown function in the
cytoplasm of the parasite.
 |
EXPERIMENTAL PROCEDURES |
Trypanosomes, Cell Culture, and Transfection--
Bloodstream
forms of the pleomorphic T. brucei brucei clone AnTat1.1
were grown in rodents as described (22). The monomorphic clone MiTat1.4
(23) was cultured in HMI-9 medium (24) supplemented with 10% (v/v)
heat-inactivated fetal bovine serum but without Serum
PlusTM at 37 °C and 5% (v/v) CO2. Procyclic
forms were cultured at 27 °C in SDM-79 (25) supplemented with 10%
(v/v) heat-inactivated fetal bovine serum. Bloodstream forms were
purified from host blood by ion exchange chromatography (26) on
DEAE-Sephacel (Amersham Pharmacia Biotech) columns. For stable
transfection, 10 µg of NotI-linearized plasmid DNA was
electroporated (BTX 600 Electro Cell Manipulator, 1.2 kV, 25 microfarads, 186 ohms, 2-mm electrode distance) into 4 × 107 MiTat1.4 bloodstream forms in a volume of 0.5 ml (27).
After 24 h, cells were selected with 0.5 µg/ml phleomycin, and
after several passages, drug-resistant pools were differentiated
in vitro into procyclic forms as described before (22).
Genomic Cloning--
The consensus motifs IGTDSHT and
NM(C/G)(A/P)E(I/Y)GA from the first and second domain of aconitases and
IRPs of several species (underlined in Fig. 3) were selected
to design pools of degenerate primers as follows: sense primer 5'
ATHGGNACNGAYTCNCAYAC 3' (768-fold degenerated) and antisense primer 5'
GCNCCRTAYTCNGSRCMCATRTT 3' (1024-fold degenerated) were used to amplify
1 µg of genomic AnTat1.1 DNA (30 cycles, 1.5 min 94 °C, 2 min
45 °C, and 2 min 72 °C) using Pfu polymerase
(Stratagene). Products of expected size (300 bp) were cloned into a
SmaI-linearized pBluescriptSKII(+) vector and transformed
into Escherichia coli XL-1 Blue MRA (Stratagene). Genomic
T. brucei DNA was cut with SacII and
PstI and separated on a preparative 0.8% (w/v) agarose gel,
and individual size fractions in the range of 3-4 kb were eluted. The
fraction containing the 3.6-kb SacII-PstI
fragment (Fig. 2) was identified by Southern blotting and was used to
construct a library in plasmid pBluescriptSKII(+) cut with
SacII and PstI which was transformed into
E. coli DH5 . Tbaco1.1 (Fig. 2) was isolated by two rounds
of bacterial colony screening with the 311-bp TbACO fragment
as probe. For inverted PCR of the 3'-end of TbACO, genomic T. brucei AnTat1.1 DNA was digested with SacII and
separated on a preparative 0.8% (w/v) agarose gel, and the size
fraction between 5 and 7.5 kb in size was isolated and circularized
with T4 DNA ligase. For amplification, the nested primer pairs 5'
CGGGCAAGATACTCAAGGTTCACT 3' (JS/5.4) plus 5' GGCGACTCCATAACCACAGACCAT
3' (IRP.4) and 5' CTCTTGTGGCAGTTCTCGC 3' (JS5-2) plus 5'
ACGGCTCTTCCTTCAGTG 3' (IRP.1) were used.
cDNA Cloning--
For 5'-RACE, 20 µg of total RNA isolated
from procyclic forms of AnTat1.1 were reversely transcribed with the
TbACO sequence-specific oligonucleotide 5'
GGGAACGCCAGTGAAGTC 3' (JS5-1) and SuperscriptTM Reverse
Transcriptase (Life Technologies, Inc.). After RNA hydrolysis the
cDNA was PCR-amplified with a primer matching the spliced leader
sequence of T. brucei, 5'
GGGAATTCCGCTATTATTAGAACAGTTTCT 3' (where underlines
indicate restriction sites) and the nested TbACO-specific
primer JS5-2 (see above). The resulting PCR fragment was digested with
EcoRI and EcoRV and cloned into
pBluescriptSKII(+) cut with EcoRI and HincII. For
cDNA cloning of the 3'-end of the gene, reverse transcription was
primed with a XhoI/SalI/ClaI
d(T)17 primer (5'
GACTCGAGTCGACATCGAT17 3') followed by PCR with
the adaptor primer 5' GACTCGAGTCGACATCG 3' and the
TbACO-specific nested primers 5' ATGGCAGGAATCCACATA 3'
(RIRP-2) and 5' TGCCAACACCCGACTTG 3' (RIRP-1) or with adaptor primer
and primer 5' GGGAACTATGTGTGATGAGG 3' (IRP.6).
DNA Sequencing--
The sequence of the antisense strand was
determined from overlapping deletion clones of plasmid Tbaco1.1,
constructed as recommended by the supplier of the Nested Deletion Kit
(Amersham Pharmacia Biotech). The nucleotide sequences of the sense
strand, of cDNA clones, and of the genomic clone obtained by
inverted PCR were determined by primer walking. The
SequenaseTM version 2.0 Sequencing Kit (U. S. Biochemical
Corp.) and a fluorescent dideoxynucleotide terminator cycle sequencing
kit (Applied Biosystems) were used for manual and automated sequencing, respectively.
Plasmid Constructs and Site-directed Mutagenesis--
The
complete coding region of TbACO was assembled from a 104-bp
PstI-EcoRV fragment derived from a 3'-RACE clone
and the genomic clone Tbaco1.1 opened with PstI (partial
digest) and XbaI (blunted). For convenient cloning, a
TbACO cassette was constructed as follows: a
BamHI site was introduced immediately upstream of the start codon by recombinant PCR using the primers 5'
CGGGATCCATGCTCAGCACGATGAAG 3' and JS5-2 (see cDNA
cloning), and a BglII site was introduced exactly after the
stop codon with the primers RIRP-2 (see cDNA cloning) and 5'
GAAGATCTCTACAAATTACCCTTGATT 3'. The cassette was then
recloned between BamHI and SalI of
BluescriptSKII( ). Details of these constructions are available upon request.
For bacterial expression, the following TbACO fragments were
cloned into the hexahistidine tag expression vector pQE30 (Qiagen): a
StuI-PstI fragment of Tbaco1.1 resulting in
pQE31/13 (88 kDa), a BamHI-PstI fragment of
Tbaco1.1 resulting in pQE30/4 (90 kDa), and the full-length
TbACO cassette excised with BamHI and
SalI resulting in pQE30/5 (99 kDa). A Cys-446 Ser point
mutation and a Cys-512 Ser/Cys-515 Ser double point mutation
were introduced into TbACO using the TransformerTM
Site-directed Mutagenesis Kit (CLONTECH). To this
end, a 302-bp ApaI-SmaI fragment of plasmid
Tbaco1.1 was subcloned into pBluescriptSKII( ), and the mutagenesis
was performed using the mutation primer MP1 5'
GCTATTACTTCCTCTACAAACACCTCG 3' and the selection primer Sp1 5' GTGACTGGTGAATACTCAACCAAG 3'. For the double mutant, a
SmaI/SalI 1273-bp fragment of pQE30/5 was
subcloned into pBluescriptSKII( ), and the mutation primer MP2 5'
CGGGGTACGGCAGCATGACAAGCATCGGGAATG 3' and the
selection primer Sp1 were used (nucleotide mismatches are underlined).
The mutagenized fragments were verified by sequencing and were cloned
into pQE30/5 in exchange to the respective wild type fragments.
For expression of C-terminally tagged TbACO in trypanosomes, the
insertion vector pLew20 which targets the rDNA spacer of T. brucei (28) was opened with HindIII and
BamHI; the ends were blunted, and the vector fragment was
gel-purified. The Ty-1 epitope (29) was attached to the C terminus of
TbACO by recombinant PCR using the TbACO-specific primer 5'
ATGGCAGGAATCCACATA 3' and the Ty-1 primer 5'
GCTCTAGACTAGTCAAGTGGATCCTGGTTAGTATGGACCTCCAAATTACCCTTGATTTTC 3' including an XbaI site. The resulting PCR fragment
was cleaved with XbaI, blunted, and then cleaved with
Eco47III. The TbACO cassette was cut with
BamHI, blunted, and then cut with Eco47III, followed by isolation of the fragment. The three fragments were ligated
together to give pLewacotag.
Southern Blot Analysis--
Genomic DNA was prepared by phenol
extraction, dialysis, and isopropyl alcohol precipitation. After
electrophoresis in TAE buffer, agarose gels were blotted onto a
GeneScreenTM nylon membrane (NEN Life Science Products) by
capillary transfer. The hybridization and washing temperatures were
adjusted to 5 °C below the calculated melting temperature of
specific DNA-DNA hybrids for high stringency conditions and to 40 °C
below the calculated melting temperature for low stringency conditions, using the buffers described in Boshart et al. (30). A
TbACO-specific probe of defined length (nucleotides
1778-2088 of Tbaco1.1) was generated by primer extension (31) with
polylinker-specific primers (SK and KS) using as template an
EagI- and ApaI-cut pBluescript plasmid containing
the 311-bp PCR fragment.
Northern Blot Analysis--
Total RNA was isolated using the
guanidinium isothiocyanate/CsCl2 cushion method (32) and
was fractionated on 1.2% (w/v) formaldehyde-agarose gels and blotted
onto GeneScreenTM (NEN Life Science Products) nylon
membrane. A riboprobe corresponding to nucleotides 1778-2088 of
Tbaco1.1 was prepared and hybridized as described (30)· The blot was
washed three times for 30 min in 0.1× SSC, 1% (w/v) SDS at 65 °C.
For control, the same blot was probed with the random prime-labeled
plasmid pR4 containing part of the rRNA locus (33)·
Bacterial Expression of TbACO--
E. coli M15rep4
(34) transformed with pQE30/5 was grown in LB medium containing 100 µg/ml ampicillin and 25 µg/ml kanamycin up to an
A600 of 0.7, and TbACO expression was induced by
addition of 1 mM IPTG for 3 h at 25 °C. Bacteria
were freeze/thaw lysed and sonicated in 50 mM
NaxHyPO4 buffer, 300 mM NaCl,
pH 8.0, 40 µg/ml bestatin, 1 µg/ml leupeptin, 0.5 µg/ml Pefabloc® (Roche Molecular Biochemicals) and 0.7 µg/ml pepstatin. The soluble material was purified by metal chelate affinity
chromatography on a Ni2+-NTA column (Qiagen) according to
the manufacturer's protocols. The yield was in the range of 230 µg
of soluble protein from 1 liter of culture. For further purification,
this protein was dialyzed against 20 mM Tris-HCl, pH 7.5, 5% (v/v) glycerol and subjected to ion exchange chromatography on a
MonoQ HR 5/5 column (Amersham Pharmacia Biotech). The N terminus of the
recombinant protein was verified by microsequencing; an amino acid
analysis gave results compatible with the predicted sequence of
recombinant TbACO, and a mass spectrum gave a value of 99902.5 mass
units compared with a theoretical value of 99702.7 (all performed by
the protein chemistry core facility of the MPI for Biochemistry).
Enzyme Assays--
For aconitase activity measurements,
recombinant full-length TbACO (99 kDa) was expressed and purified as
described above, except that all buffers contained 10 mM
citrate and 2 mM -mercaptoethanol and were degassed and
saturated with nitrogen. The aconitase substrate citrate protects from
oxidative inactivation (35). For concentration and buffer exchange (50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 10 mM citrate, 1 mM DTT), CentriconTM
100 ultrafiltration units (Amicon) were used. Protein samples were
stored in a glove bag under argon or nitrogen atmosphere at 4 °C.
Iron loading under reducing conditions was performed in a glove bag
with 200 µg of protein (in 20 mM Tris-HCl, pH 7.5) by
adding 10× loading buffer (10 mM MES, pH 5.5, 10 mM ferrous ethylenediammonium sulfate, 50 mM
DTT) and incubating for 25 min at 37 °C similar as described by
Kennedy et al. (36). The loaded protein was aliquoted and
stored on ice in nitrogen atmosphere until measurement of activity with
a double beam photometer (Perkin-Elmer Lambda 5). For the UV assay
described by Henson and Cleland (37), 1 ml of 90 mM
Tris-HCl, pH 7.5, containing DL-isocitrate (Sigma) ranging
from 1 to 20 mM was equilibrated at 25 °C, and the
formation of cis-aconitate was recorded for 6 min
(extinction coefficient for cis-aconitate = 3.4 mM 1 cm 1 at 240 nm). Assuming
Michaelis-Menten kinetics, nonlinear curve fitting of kinetic data was
performed with Kaleidagraph 3.0.8 (Synergy Software) and the
Km and Vmax values were
calculated from a reciprocal plot according to Hanes (38). Aconitase
activity in whole cell extracts was measured as described by Overath
et al. (7). Protein concentrations were determined using the
Bradford assay as supplied by Bio-Rad and bovine serum albumin as standard.
Antibodies--
For the first series of immunizations (including
"rat 1"), an 88-kDa recombinant TbACO fragment (pQE31/13) was
purified by Ni2+-NTA chromatography, electrophoresed on an
8% (w/v) SDS-polyacrylamide gel, and blotted onto nitrocellulose
membrane. The 88-kDa band was excised from the membrane (150-200 µg
of protein), and the dried nitrocellulose was powdered, emulsified with
complete Freund adjuvant, and injected intraperitoneally in female
Wistar rats. Rats were boostered once with 150 µg of protein after 4 weeks. Two weeks later, the animals were bled, and sera were affinity purified as described (39). For a second series of immunizations (including "rat 2" and "rabbit 1") the recombinant full-length TbACO (pQE30/5) was purified by Ni2+-NTA chromatography in
soluble form and directly emulsified with complete Freund adjuvant.
Rabbits were immunized by subdermal injection of 500 µg of protein
followed by 3 booster injections at regular intervals. Rabbit
anti-phosphoglycerate kinase C antibodies were a kind gift of P. Michels. Rabbit anti-Synechococcus sp. HSP60 antiserum was
purchased from StressGen Biotechnologies Corp. The BB2 hybridoma
(anti-Ty1 monoclonal antibody) was a kind gift of P. Bastin and K. Gull. Rabbit anti-Dictyostelium -tubulin antiserum was
obtained from G. Gerisch.
Immunoblot Analysis--
Whole cell extracts were prepared by
transferring small volumes of PBS-washed and resuspended trypanosomes
into SDS-lysis buffer preheated to 100 °C. Samples were boiled for 5 min and sonified. Proteins were separated on 8% (w/v)
SDS-polyacrylamide gels and were transferred onto HybondTM
polyvinylidene difluoride membranes (Amersham Pharmacia Biotech) using
a semi-dry blotting procedure (40). Membranes were blocked overnight in
TBST (25 mM Tris-HCl, pH 8, 150 mM NaCl, 0.1%
(v/v) Tween 20), 5% (w/v) dried milk powder, incubated for 1 h
with primary antibodies (1:1000) in TBST, 5% (w/v) dried milk powder, washed in TBST, and incubated with a second antibody conjugated to
horseradish peroxidase or alkaline phosphatase for 1 h. Membranes were developed using the ECL detection kit (Amersham Pharmacia Biotech)
or incubated in staining solution (0.41 mM NBT; 0.38 mM 5-bromo-4-chloro-3-indolyl phosphate; 4 mM
MgCl2; 0.1 M Tris-HCl, pH 9.5), respectively.
Exposed films were scanned on a flat bed scanner (AGFA, model Arcus
II), and the signals were quantified using NIH image software (version
1.60). Alternatively, the primary antibody was followed by a 1-h
incubation with 1 µCi of 125I-protein A (70-100
µCi/µg), several wash steps in TBST, and autoradiography on a
PhosphorImager (Molecular Dynamics).
Digitonin Fractionation--
Cell fractionation was essentially
done as described by Häusler et al. (41). Aliquots of
2.5 × 107 procyclic cells were washed in 25 mM Tris-Cl, pH 7.8, 1 mM EDTA, 0.6 M sucrose, 1 mM DTT, 2 µg/ml leupeptin and
were resuspended in 1.12 ml of the same buffer, and 125 µl of
prediluted digitonin was added while mixing. After 2 min at 37 °C
and 10 s on a Vortex mixer the cells were centrifuged at
12,000 × g at 4 °C for 10 min. The supernatant was
concentrated by ultrafiltration using MicroconTM 30 (Amicon) before SDS-PAGE and immunoblotting of aliquots of both fractions.
Immunofluorescence--
Short stumpy bloodstream forms were
freshly isolated from infected mouse blood by centrifugation (22) and
were stained with the mitochondrion-selective dye MitoTracker green
FMTM (Molecular Probes) as described (42). Cells were then
fixed in 3% (w/v) paraformaldehyde in PBS, permeabilized with 0.1%
(v/v) Triton X-100 in PBS, and stained for 1 h with rabbit
anti-TbACO antiserum or preimmune serum (Fig. 7A) diluted
1:10 in PBS, 1% (w/v) bovine serum albumin. Texas
RedTM-conjugated goat anti-rabbit IgG F(ab')2
fragments (Dianova) were used as secondary antibodies. Washed cells
were mounted in VectaShieldTM (Vector) on
3-aminopropyltriethoxy-silane-coated slides and were examined with a
Zeiss Axiophot 2 microscope equipped with a Plan-Apochromat 63×
objective (NA 1.4). Images were recorded with a cooled digital CCD
camera (MicroMAX, Princeton Instruments).
Evolutionary Analysis--
The multiple sequence alignments were
generated with ClustalW, version 1.60 (43), and manual editing. The
total length of the alignment comprises 1171 sites and is available
upon request. To reconstruct phylogenetic trees based on the amino acid
sequence alignment, the PUZZLE program (version 4.0) was applied (44, 45). As substitution model the substitution matrix BLOSUM 62 (46) was
assumed. To account for rate heterogeneity a discrete Gamma model (47)
with four categories was introduced, and the corresponding shape
parameter was estimated. For each sequence we tested if the base
composition deviates significantly from the average composition. The
estimated shape parameter of the gamma distribution equals 1.17, thus
indicating weak rate heterogeneity.
 |
RESULTS |
Cloning of an Aconitase Gene of T. brucei--
Highly degenerate
pools of PCR primers matching two conserved sequence motifs of the
aconitase gene family were used to amplify genomic T. brucei
DNA. Ten out of 31 clones derived from a PCR product of expected size
contained the same 311-bp insert with an uninterrupted open reading
frame exhibiting 74% protein sequence similarity to human IRP-1 and
75% similarity to Arabidopsis thaliana aconitase. No other
aconitase family-related sequence was detected with this and other
pairs of degenerate primers. The cloned 311-bp fragment was used to
probe Southern blots of genomic DNA. Each restriction enzyme digest
produced a single specific band with different mobility, indicating a
single copy gene (Fig. 1). Low stringency
hybridization conditions (40 °C below Tm) revealed only one additional sequence (marked with asterisks
in Fig. 1) which was cloned from a phage library. The cross-hybridizing fragment did not exhibit any nucleotide sequence similarity to the
aconitase gene family. Thus, the hybridization conditions used must
have been sufficiently relaxed and sensitive for detection of
TbACO-related genes. A restriction map of the
TbACO locus was constructed from multiple digests, and a
genomic 3.6-kb SacII-PstI fragment was cloned
(plasmid Tbaco1.1, see "Experimental Procedures" and Fig.
2) which contained a long open reading
frame devoid of a stop codon. Therefore, a cDNA containing the
missing C terminus was cloned by reverse transcriptase-PCR with nested
TbACO-specific primers. An 800-bp internally primed cDNA
was obtained. Therefore, the 3'-end of the gene was cloned by inverted
PCR (see Fig. 2 and "Experimental Procedures"). The length of the
5'-UTR of the TbACO transcript was determined by a modified
5'-RACE strategy exploiting the conserved mini-exon sequence present at
the 5'-end of all trypanosomal mRNAs. The sequence of three
independent clones derived from the single PCR product showed that the
mini-exon was added at a trans-splice site (AG dinucleotide)
at position 100 relative to the first ATG codon. As expected for a
canonical trans-splice site, several polypyrimidine
stretches were found within 50 bp upstream of the AG.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 1.
TbACO copy number and related
sequences in the T. brucei genome. Genomic
T. brucei AnTat1.1 DNA was digested with EcoRI
(E), HindIII (H), or PstI
(P), and 5 µg were loaded per lane on a 0.8% (w/v)
agarose gel. Dilutions of a cloned TbACO fragment were
loaded as sensitivity markers equivalent to 0.5, 1, and 5 copies per
haploid genome (0.5, 1, and 5×). The Southern blot was probed with the
311-bp PCR fragment (see Fig. 2) labeled with
[ -32P]NTPs by primer extension. One additional weakly
cross-hybridizing sequence (bands marked with an asterisk)
was detected at low hybridization stringency (40 °C below the
calculated melting point (Tm) of the probe) but not
at stringent conditions (5 °C below Tm, not
shown).
|
|

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Restriction map of the TbACO
locus and cloning strategy. Genomic cleavage sites of
EcoRI (E), HindIII (H),
PstI (P), and SacII (S) are
indicated for strain AnTat1.1 of T. brucei. The blow up
represents the genomic SacII-PstI fragment (clone
Tbaco1.1, GenBankTM accession number AF127456) that was
isolated by screening with the 311-bp PCR fragment indicated by a
hatched box. The TbACO open reading frame is
boxed. The cDNA at the 3'-end (reverse
transcriptase-PCR, GenBankTM accession number AF127457) was
amplified with nested gene-specific primers RIRP2 (3) and RIRP1 (4).
Four independent cDNA clones contributed 75 amino acids of coding
region (boxed) as well as 254 bp of 3'-UTR. The
trans-splice site (marked by an AG dinucleotide) at position
100 relative to the first ATG was determined from the sequence of 3 independent 5'-RACE clones amplified with nested gene-specific primers
JS5-1 (1) and JS5-2 (2). The 3'-end of the gene was cloned by inverted
PCR (INV-PCR, GenBankTM accession number
AF190556) using the nested primer pairs JS/5.4 (5) plus IRP.4 (6) and
JS5-2 (2) plus IRP.1 (7). The 3'-ends of TbACO transcripts
(wavy lines) were mapped by 3'-RACE PCR using the
gene-specific primer IRP.6 (8). Two PCR products of 500 and 810 bp
(indicated by arrows) were obtained, thus calculated sizes
of TbACO mRNAs (without poly(A)-tail) of 4197 and 4507 nt, respectively. The transcript sizes estimated from Northern blots
(see Fig. 6) are indicated (4.2 and 4.7 kb).
|
|
The TbACO Protein Sequence--
The open reading frame predicted a
protein of 897 amino acids with a calculated molecular mass of 98,302 Da and a pI of 6.48. Both methionines at positions 1 and 5 are in
sequence environments compatible with the requirements for translation
initiation (48). Thus, use of the first ATG is assumed. Pairwise
alignments of TbACO with other members of the aconitase family show a
very high degree of amino acid identity and similarity with vertebrate
IRPs and with plant aconitases (58/74% with human IRP-1; 61/75% with A. thaliana aconitase) extending over the entire length of
the proteins. In contrast, mitochondrial aconitases of mammals or S. cerevisiae are significantly more distant (30% identity,
55% similarity). A multiple sequence alignment of TbACO with a
representative member of each aconitase subfamily is shown in Fig.
3. From the crystal structure and
mutation analysis of porcine mitochondrial aconitase, 24 residues were
identified as important for coordination of the [4Fe-4S] cluster, for
substrate recognition and catalysis, and for support of active site
chains by hydrogen bonds (49-52). Table
I lists the homologous positions in
TbACO, showing that 21 of 24 positions are conserved. Asparagine 170 and alanine 74 of pig mitochondrial aconitase have been implicated in
hydrogen bonding with other active site residues but are not conserved in the Fe-S isomerase family (53). In TbACO these positions are
substituted by methionine (Met-222) and phenylalanine (Phe-100), respectively, like in mammalian IRPs and plant aconitases (see Fig. 3).
Arginine 580 that appears to be a key residue for substrate binding in
pig mitochondrial aconitase (52) has been replaced by leucine (Leu-702)
in TbACO. This position is only substituted in two other aconitase
sequences, that of Legionella pneumophila (54) and a
hypothetical aconitase of S. cerevisiae (hACO) identified by
genome sequencing (55). A multiple alignment of Frishman and Hentze
(53) has identified 26 additional residues that are highly conserved in
the Fe-S isomerase family (marked with an asterisk in Fig.
3). Of these, only one glycine (Gly-413 of pig mitochondrial aconitase)
is substituted by arginine (Arg-504) in the TbACO sequence.

View larger version (101K):
[in this window]
[in a new window]
|
Fig. 3.
Multiple sequence alignment of deduced TbACO
amino acid sequence with representative aconitase family members.
A. thaliana aconitase (78), GenBankTM accession
number X82839, human IRP-1 (108), GenBankTM accession
numbers M58510 and M37835, and porcine mitochondrial aconitase (109),
GenBankTM accession number J05224 are aligned with TbACO.
The numbering of Rutgers University Protein Database (110) entry 7ACN
was adopted for pig heart aconitase. The alignment was compiled by
ClustalW, version 1.60 (43), with default settings (gap opening penalty
of 10 and gap extension penalty of 0.05). The presequence of porcine
mitochondrial aconitase was not included, and manual adjustments of the
alignment were made at the N terminus. Sequence identity with TbACO is
indicated by gray background, and active site residues (see
Table I) are highlighted in black with white
lettering. Additional residues highly conserved in the FeS
isomerase family (53) are marked by an asterisk. The motifs
initially chosen for design of degenerate PCR primers (see
"Experimental Procedures") are underlined.
|
|
The high degree of sequence similarity of TbACO with IRPs, and the fact
that trypanosomes represent the earliest branch of extant eukaryotes
that harbor mitochondria (56), solicited a phylogenetic analysis.
Sequences of 22 aconitases and IRPs available in data bases were
aligned. As outgroup, sequences served 10 isopropylmalate isomerase and
bacterial aconitase B group sequences that are significantly different.
A PUZZLE tree based on 32 aligned sequences was reconstructed. For the
22 aconitase and IRP sequences a PUZZLE tree was computed and rooted
according to the big tree (Fig. 4). The
general topology of the tree is very similar to published trees of the
aconitase family (53, 57, 58). TbACO is clearly separated from the mitochondrial aconitases. Within the IRP-like subfamily, TbACO, plant
aconitases, bacterial aconitases, and IRPs all branch from one node,
and it is not possible to resolve the branching pattern any further.
The statistical support for any particular topology linking TbACO to
either the IRP cluster or the plant aconitase cluster is weak. This is
congruent with recent evidence for an overestimation of the divergence
of protists and crown eukaryotes, based on nuclear gene data, and the
proposal of a "big bang" radiation of the various eukaryotic
lineages (reviewed in Ref. 59).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 4.
Phylogenetic tree of the aconitase
family. A PUZZLE tree was calculated for an alignment of 22 aconitases and IRPs (see "Experimental Procedures"). The tree was
rooted with the information from a second tree that included 10 outgroup sequences (isopropylmalate isomerases and bacterial aconitase
B group). The numbers along the edges indicate the support
values (% of trees in a sample of 10,000 trees that show the same
grouping (44)). The branch length is a measure of the number of
substitutions (see scale). All sequences used for the alignment are
available in public data bases. Accession numbers are listed in Refs.
55, 58, and 73.
|
|
Enzymatic Activity and Kinetic Properties of Recombinant
TbACO--
The complete open reading frame of TbACO was
fused to a hexahistidine tag at the N terminus, and the fusion protein
was expressed in E. coli and purified by affinity
chromatography on a metal chelate resin (Fig.
5A). Aconitase activity
increased linearly with the amount of recombinant protein and was
maximal between pH 7 and 8 (not shown). The activity was dependent on
loading of the protein with Fe2+ in the presence of DTT and
was sensitive to oxygen (Table II), consistent with the presence of a labile [4Fe-4S] cluster (14, 36,
60). The conserved cysteine positions of TbACO ligating this putative
iron-sulfur cluster (see Table I) were then substituted by serines by
site-directed mutagenesis. Two recombinant mutant proteins (C446S and
C512S/C515S) were purified and iron-loaded exactly as the wild type
protein. As expected, no enzymatic activity could be detected (Table II
and data not shown). The analogous mutations in human IRP-1 also
abolished enzymatic activity (61, 62). This control provided
unambiguous evidence that we had cloned an aconitase. The specific
activity under Vmax conditions was determined
using >95% pure recombinant enzyme prepared by further purification
on a MonoQTM ion exchange column (Fig. 5A). The
result was close to specific activities reported for bovine heart
mitochondrial aconitase (30 µmol min 1 mg 1
(36, 52)), bovine IRP (34 µmol min 1 mg 1
(63)), and potato tuber mitochondrial aconitase (32 µmol
min 1 mg 1 (64)). The Michaelis-Menten
constant (Km) for the substrate isocitrate was
determined from reaction velocity plots and derived reciprocal Hanes
plots as shown in Fig. 5B. The resulting Km of 3 ± 0.4 mM is about 1 order
of magnitude higher than published values for pig heart mitochondrial
aconitase (65). This can be correlated with the substitution of an
active site residue implicated in substrate binding (Leu-702 in TbACO
substituting Arg-580 in pig mitochondrial aconitase, see Table I). In
fact, an R580K mutant of pig mitochondrial aconitase (52) exhibits a
30-fold reduced Km, nearly complete loss of tight
substrate binding, and a 250-30,000-fold decreased activity, depending
on the substrate. The ratio of the activities with isocitrate and citrate is 2.1 for the wild type but 11 for the R580K mutant (52). For
TbACO, this ratio was 1.6 and the specific activity was close to that
of wild type pig mitochondrial aconitase (Table II). This is even more
surprising as the positive charge of the residue, which is thought to
interact with the -carboxyl of substrates, is maintained in the
R580K mutant of pig mitochondrial aconitase but replaced by the
hydrophobic side chain of a leucine in TbACO. Thus, it seems that in
TbACO a slightly different network of hydrogen bonds holds the
substrate in place and substitutes for the proposed essential function
of Arg-580 in the prototype aconitase structure (51, 66).

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Kinetic analysis of recombinant TbACO.
Hexahistidine-tagged TbACO was expressed in E. coli and
purified as described under "Experimental Procedures."
A, Coomassie Brilliant Blue-stained (1st to 3rd
lanes) or silver-stained (4th lane)
8% (w/v) SDS-PAGE: 1st lane, bacterial lysate of
the transformed E. coli M15rep4 ( IPTG);
2nd lane, lysate prepared after induction of
bacteria for 3 h with 1 mM IPTG at 25 °C
(+IPTG); 3rd lane, protein eluted from
a nickel chelate affinity column
(Ni2+-NTA); 4th
lane, protein eluted from a second step MonoQ HR 5/5 ion
exchange resin (MonoQ). Most of the faster migrating bands detected by
silver staining (4th lane) are degradation
products as indicated by immunoreactivity with anti-TbACO antibodies
(not shown). TbACO eluted from Ni2+-NTA was activated with
Fe2+ and DTT under nitrogen atmosphere. Kinetic
measurements with activated protein were performed with isocitrate as
substrate, and formation of cis-aconitate was monitored
spectroscopically at 240 nm. B, data representation as
reciprocal [S/v]/[S] plot according to Hanes (38) with
the original [v]/[S] (S, substrate concentration;
v, reaction velocity) plot as inset.
Dots indicate mean values, and error bars
indicate standard deviations of a triplicate measurement.
Km = 2.9 mM and
Vmax = 10.6 µmol min 1
mg 1 were determined from the experiment shown. A mean of
Km = 3 ± 0.4 mM for the substrate
isocitrate was calculated from five measurements with three independent
protein preparations.
|
|
Differential Expression in the Life Cycle--
A major
TbACO transcript of 4.7 kb and a minor transcript of 4.2 kb
were detected by Northern hybridization in three life cycle stages of
T. brucei. The use of two polyadenylation sites was
confirmed by mapping the cDNA with 3'-RACE-PCR (Fig. 2). No difference in total mRNA abundance was noted between stumpy
bloodstream forms and procyclic forms, and the sum of the two
transcripts was only slightly reduced in slender bloodstream forms
(Fig. 6). Regulation appeared to be more
prominent for the smaller mRNA; however, its contribution to the
total amount of aconitase-specific mRNA was less than 30%. To
investigate TbACO protein expression, antisera were produced in rats
and rabbits by immunization with purified recombinant TbACO.
Irrespective of the animal species and immunization procedure (see
"Experimental Procedures"), one single polypeptide of 98 kDa was
detected in procyclic whole cell lysates, in agreement with a predicted
molecular mass of 98,302 Da. No signals were detected by the respective
nonimmune or preimmune sera (Fig.
7A). TbACO expression was then
compared in slender and stumpy bloodstream populations and in procyclic
forms of the pleomorphic strain AnTat 1.1. The maximal amount of
protein was detected in the procyclic stage (Fig. 7B).
Expression in the slender bloodstream stage was less than 4% of the
procyclic level, and stumpy populations were found to be intermediate.
The same result was obtained with trypanosomes harvested from several
independent rodent infections and upon probing with different antisera
(not shown). The absolute TbACO abundance was estimated by comparison with standard dilutions of purified recombinant TbACO in the Western blot shown in Fig. 7C and calculated to be close to 160,000 molecules per procyclic cell. The fraction of stumpy forms in the
predominantly slender or predominantly stumpy populations was
determined by cytochemical staining for the stumpy marker activity NADH
dehydrogenase (6) (see legend to Fig. 7). After correction, an
estimation of 40,000 molecules per stumpy cell and 5000 molecules per
slender cell was reached. In summary, developmental regulation of TbACO is more than 30-fold. This contrasts with a very minor change in
mRNA expression. Thus, developmental control of expression must
operate at the translational or post-translational level.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 6.
Developmental profile of TbACO
mRNA expression. A Northern blot with 5 µg of total
RNA isolated from a long slender (LS) bloodstream form
population, a short stumpy (SS) bloodstream form population,
and cultured procyclic forms (PCF) of strain Antat1.1 was
probed with a riboprobe derived from the coding region of
TbACO. In the SS population, 90% of the cells expressed the
stumpy cell marker NADH dehydrogenase, as assayed by cytochemical
staining (6). Equal loading of samples was internally controlled by
rehybridization of the blot with a rDNA probe detecting the 18 S rRNA
and the - and -segments of 28 S rRNA. The relative abundance of
the sum of the two TbACO transcripts marked with
arrowheads was determined by densitometry and normalization
to the rRNA signals (relative values are 1, 1.57, and 1.77 for LS, SS,
and PCF, respectively). The size marker is an RNA ladder from Life
Technologies, Inc.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Developmental profile of TbACO protein
expression. Several antisera were raised in rats and rabbits
against recombinant TbACO as detailed under "Experimental
Procedures" to determine TbACO protein expression in different life
cycle stages of T. brucei. A, Western blots documenting the
specificity of three selected sera raised against a denatured 88-kDa
rTbACO fragment (rat 1) or against the full-length 99-kDa
rTbACO purified under native conditions (rat 2, rabbit 1).
The equivalent of 5 × 106 procyclic trypanosomes per
lane was run on 8% (w/v) SDS-PAGE and probed with nonimmune serum
(ni, from a control animal of the same rat strain) or immune
serum (i), or matched preimmune serum (pi) at the
following dilutions: 1:500 for affinity purified sera from rat 1 and
rat 2 and affinity purified controls; 1:100 for serum and control from
rabbit 1. For detection, the ECL kit (1st to 4th
lanes) or an alkaline phosphatase-catalyzed color reaction
(5th and 6th lanes) were used.
B, lysates (two independent preparations for each
developmental stage) of 5 × 106 long slender forms
(LS, lane 1), 2 × 106 long
slender forms (LS, lane 2), 2 × 106 short stumpy forms (SS, lanes 3 and 4), or 2 × 106 procyclic forms
(PCF, lanes 5 and 6) of AnTat1.1 were
size-fractionated by SDS-PAGE. The developmental stage of bloodstream
form populations was verified with an established stumpy marker, NADH
dehydrogenase, using cytochemical staining according to Vickerman (6).
The slender populations contained <3% positive cells, and the stumpy
populations contained >85% positive. TbACO was detected with purified
rabbit 1 antibody (1:1000), and tubulin (TUB, internal
control) was detected with rabbit anti-(Dictyostelium
-tubulin) serum (1:1000), followed by 125I-protein A. Relative normalized intensities of TbACO bands as derived from
PhosphorImager scans of 125I and the fold regulation
(average of n = 2) are indicated below the
lanes. All samples were run on the same gel. C, absolute
quantification of TbACO by Western blotting of a lysate from PCF
together with dilutions of a highly purified rTbACO standard (see under
"Experimental Procedures"). Affinity purified antibodies from rat 2 (1:500) and the ECL kit were used for detection. Relative intensity
values derived from densitometry are indicated below the
lanes. Linear regression analysis of the scanned standard signals was
used for calculation.
|
|
Subcellular Localization--
The high sequence similarity of
TbACO to IRPs, which are cytoplasmic regulatory proteins in mammalian
cells, raised the question of its subcellular localization. TbACO was
present but not enriched in a partially purified mitochondrial vesicle
fraction prepared according to Ref. 67 (a kind gift of H. U. Goeringer, data not shown). This suggested multicompartmentalization of
the protein. Therefore, procyclic trypanosomes were fractionated after
differential permeabilization with digitonin. Based on different
cholesterol content of the membranes, only the plasma membrane is
permeabilized at low digitonin concentrations, whereas organellar
membranes require higher concentrations (68-70). Phosphoglycerate
kinase B and the mitochondrial heat shock protein HSP60 were used as markers for the cytosolic and mitochondrial fractions, respectively, as
described before (41). Procyclic cells were incubated with increasing
concentrations of digitonin, followed by centrifugal separation of
soluble and particulate fractions. The amount of TbACO and of the
marker proteins in each fraction was quantified by densitometric
scanning of Western blots (Fig. 8,
A and B). About 70% of total TbACO was released
into the supernatant together with the cytosolic marker
phosphoglycerate kinase B at 0.5 mg of digitonin per mg of cellular
protein. The remaining part of TbACO appeared to be as resistant to
solubilization as the mitochondrial matrix marker HSP60. To exclude the
possibility that our antibodies cross-reacted with a different 98-kDa
protein in one of the cellular compartments, TbACO was epitope-tagged
at the C terminus with a short peptide derived from the yeast
transposable element Ty1 (29). The tagged open reading frame was
inserted into the trypanosomal expression vector pLew20 (28) and
targeted to the ribosomal spacer region of the T. brucei
genome by homologous recombination. The resulting procyclic cell line,
which expressed about the same amount of tagged TbACO as wild type
protein (not shown), was subjected to digitonin fractionation using the
same conditions as for wild type procyclic forms. Western blots were
probed with an epitope tag-specific monoclonal antibody (Fig. 8,
C and D). About 70% of the tagged TbACO was
released together with the cytosolic marker (phosphoglycerate kinase B)
at low digitonin concentrations where the mitochondrial HSP60 was
quantitatively retained in the pellet fraction. Together, these
experiments proved that about 70% of TbACO was localized in the
cytoplasm of procyclic T. brucei. Mitochondrial localization
of the remaining 30% was suggested by the fractionation; however, the
protease digestion control required to rule out nonspecific association
of TbACO with the particulate fraction was technically difficult due to
relative resistance of free TbACO to digestion. Instead, localization
of TbACO to the single mitochondrion of trypanosomes was directly
documented by immunofluorescence microscopy. In the stumpy stage, the
mitochondrion has an easily discernible tubular structure extending
over the entire length of the cell and can be visualized with the
aldehyde-fixable membrane potential sensitive fluorescent dye
MitoTrackerTM Green FM (42). Upon immunofluorescent
staining with three different TbACO-specific antisera, perfect
colocalization of the antibody signal with the MitoTracker
mitochondrial marker was observed in every cell (Fig.
9 and not shown). Double
immunofluorescent staining with TbACO antibodies and antibodies
detecting the mitochondrial matrix protein HSP60 also showed
colocalization and confirmed antibody access to the mitochondrial
matrix under the given permeabilization conditions (data not shown).
TbACO-specific cytoplasmic staining was weak, as expected from leakage
of cytoplasmic protein during permeabilization necessary for detection
of mitochondrial proteins (Fig. 9). In conclusion, TbACO has a dual
subcellular localization in the cytosol and in the mitochondrion of
T. brucei. Cytosolic and mitochondrial aconitase activity
was then measured in lysates after preparative fractionation of
procyclic trypanosomes with 0.5 mg of digitonin per mg of total
protein. The fractionation was controlled with the marker proteins
phosphoglycerate kinase B and HSP60, and the enzymatic assay showed
that 78 ± 9% of the activity was in the cytoplasmic fraction and
21 ± 2% was associated with organelles. Thus, the subcellular
distribution of aconitase activity was in agreement with the
distribution of TbACO protein.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 8.
Subcellular localization (digitonin
fractionation). Procyclic trypanosomes were subjected to
differential permeabilization by 0-10 mg of digitonin/mg of cellular
protein (concentration indicated on top of the lanes in
A and C, a different batch of digitonin was used
for C) and were subsequently fractionated by centrifugation.
Supernatant (S) and pellet (P) fractions were run
on 8 or 10% (w/v) SDS-polyacrylamide gels and were analyzed by Western
blotting using anti-phosphoglycerate kinase C serum (1:2000),
anti-HSP60 serum (1:2000), affinity purified rat anti-TbACO serum
(1:300), and anti-Ty1 monoclonal antibody (BB2 culture supernatant,
1:50) as indicated. Phosphoglycerate kinase B (PGK-B,
detected by anti-phosphoglycerate kinase C serum) served as cytosolic
marker and mitochondrial heat shock protein HSP60 served as
mitochondrial marker (41). A and B, AnTat1.1 wild
type procyclic trypanosomes (2.5 × 106 or 5 × 106 cells (for HSP60 only) per lane).
C and D, transgenic MiTat1.4 procyclic
trypanosomes stably expressing an epitope (Ty1)-tagged
TbACO. Western blots are shown in A and C, and
the corresponding quantitative data obtained by densitometric scanning
are displayed in B and D. The released fraction
(% release) is calculated by dividing the amount of
specific protein in the supernatant by the total amount of specific
protein in supernatant and pellet of the respective sample.
|
|

View larger version (117K):
[in this window]
[in a new window]
|
Fig. 9.
Subcellular localization
(immunofluorescence). Short stumpy stage bloodstream forms were
stained with the mitochondrion-selective dye MitoTracker Green
FMTM, fixed, permeabilized with 0.1% (v/v) Triton X-100,
and incubated with rabbit preimmune serum (A-C) or
anti-TbACO antiserum (D-F) and Texas
RedTM-conjugated goat anti-rabbit F(ab')2
fragments. A and D, phase contrast. B
and E, MitoTracker Green FMTM fluorescence
observed with fluorescein isothiocyanate filter set. C and
F, Texas RedTM fluorescence observed with red
filter set. Three representative cells are displayed for
D-F.
|
|
 |
DISCUSSION |
Mammalian cells have two aconitases encoded by separate nuclear
genes: (a) the mitochondrial citric acid cycle enzyme and (b) a cytoplasmic aconitase, better known as the
iron-regulatory protein (IRP-1) which acts as an iron sensor and
post-transcriptional regulator and as a signal transducer for oxidative
stress (71, 72). Since members of both aconitase subfamilies were
identified in invertebrates, e.g. Caenorhabditis
elegans and Drosophila melanogaster (73),
specialization of mitochondrial and cytoplasmic aconitase functions
seems to have occurred early during animal evolution. Here we report on
a protozoan aconitase which belongs to the IRP-1 subfamily but
localizes in the mitochondrion as well as in the cytoplasm. TbACO
accounts for total aconitase activity in T. brucei. This was
directly confirmed by enzyme assays in trypanosome lines with targeted
disruption of both alleles of TbACO. In several independent
aco::HYG/ aco::NEO procyclic
lines,2 no aconitase activity
could be detected (data not shown). The sensitivity of the enzymatic
assay does not exclude a minor activity; however, three independent
methods, PCR amplification with degenerate primers, low stringency
Southern hybridizations, and Western blotting with several TbACO
antisera (Fig. 1 and Fig. 7, and not shown), did not indicate a second
aconitase or a second IRP-related gene in T. brucei.
The mitochondrial localization of about 30% of TbACO and the absence
of a second aconitase indicate that TbACO functions in the citric acid
cycle of T. brucei. To our knowledge, this is the first
direct evidence that an IRP-like aconitase functions in mitochondrial
metabolism in a eukaryote. The dual subcellular localization resembles
the situation in plant tissues, where 50-90% of total aconitase
activity or protein reside in the cytosol and function in the
glyoxalate cycle (20, 21, 74, 75). Plant aconitase purified from
cytosol and mitochondria is indistinguishable with respect to kinetic
parameters, molecular mass (90-98 kDa), and the EPR spectrum (20, 64,
74-76). Furthermore, the molecular mass and the EPR spectrum of plant
aconitase purified from mitochondria resemble mammalian IRP but not
mammalian mitochondrial aconitase (64, 77). The three plant aconitase
sequences available so far (21, 78) are very similar to IRPs and to
TbACO but less related to the mitochondrial aconitase subfamily. Hence,
it seems likely that the mitochondrial aconitase in plants is encoded
by these IRP-related sequences, although direct evidence has yet to be
provided. Particularly, it is unknown whether the cytosolic and
mitochondrial plant aconitase isoforms, which are differentially regulated and chromatographically separable (20), derive from a single
or distinct genes. The dual localization of the T. brucei aconitase, which is similar to plant aconitases (Fig. 3), suggests that
cytosolic and mitochondrial IRP-related isoforms may indeed be encoded
by one gene in plants.
As the first IRP-like sequence from a protist, the TbACO
sequence has added valuable phylogenetic information with respect to
evolution of the aconitase gene family (53, 57, 58, 79). The fact that
TbACO forms a well supported clade together with animal
IRPs, plant aconitases, and bacterial aconitases of the E. coli
acoA type, clearly separated from mitochondrial aconitases of
yeast and animals (Fig. 4), strengthens the argument for the existence
of aconitase paralogues before the separation of eubacteria from
eukaryotes. The mitochondrial localization of TbACO and the branching
of IRP, TbACO, and bacterial aconitases from one node support the view
that the ancestor of the regulatory protein IRP was an enzyme of
mitochondrial energy metabolism which most likely was acquired from a
proteobacterial endosymbiont. It seems that members of the IRP-like and
of the classical mitochondrial aconitase subfamilies both can function
in more than one subcellular compartment. In S. cerevisiae,
which does not harbor an IRP-related gene in its genome (80), the
mitochondrial aconitase is also present in the cytosol where it
participates in the glyoxalate cycle (81). In trypanosomes, the single
IRP-like aconitase is present in the mitochondrion and in the cytosol,
and in plants, IRP-related aconitases seem to function in mitochondrial
metabolism as well as in the cytosolic step of the glyoxalate cycle
(20, 21, 75). Animals may have kept or acquired members of both
aconitase subfamilies during evolution and restricted them to one
subcellular compartment in order to specialize them for different tasks
in the mitochondrion and in the cytosol.
The distribution of one gene product between different subcellular
compartments can be achieved by a variety of mechanisms, most of which
lead to alternative transcription and/or translation initiation sites
or alternative mRNA processing (reviewed in Ref. 82). In the case
of TbACO, there is only one defined 5'-end of the mRNA and two
closely spaced potential AUG codons at positions 1 and 5. It is
difficult to imagine alternative translation initiation at these
positions to include a mitochondrial import presequence in a fraction
of the synthesized protein. Furthermore, the N-terminal sequence of
TbACO does not form an amphipathic helix and does not predict a
classical mitochondrial targeting signal. The mechanisms for protein
import in trypanosomes seem to be largely conserved (41, 83-86);
however, a second class of much shorter, typically 9 amino acid long
presequences that resemble hydrogenosomal import sequences has been
identified (87). At least one imported protein (cytochrome
c1) lacks a presequence (88), and a
nonconservative import pathway has been suggested (86). Mitochondrial
and cytoplasmic TbACO were never resolved as double band upon PAGE of
T. brucei lysates, and hence, there is no evidence for
cleavage of a leader sequence. However, cleavage of both mitochondrial
and cytosolic mature protein as shown for S. cerevisiae
fumarase FUM1 (89) cannot be excluded. All fumarase molecules
synthesized in yeast are processed by the mitochondrial matrix
protease, but nevertheless most of the enzyme (80-90%) ends up in the
cytosol. An aborted translocation process has been suggested to be
responsible for the dual mitochondrial and cytoplasmic localization of
S. cerevisiae fumarase FUM1 (89). It should be noted that
the 9 amino acid presequence of T. brucei dihydrolipoamide
dehydrogenase which is sufficient for import (85, 87) is cleaved off in
both bloodstream and procyclic forms, although the protein is not
present in the mitochondrion of slender bloodstream forms (90-93). We
suggest that multicompartmentalization of TbACO is due to inefficient targeting or an aborted translocation mechanism, possibly associated with a weak import signal deviating from the presequence consensus features.
Why do trypanosomes have a cytoplasmic IRP-like aconitase? First, it is
possible that the protein serves a gene regulatory function similar to
mammalian IRP. Recently, the Bacillus subtilis IRP-like
aconitase has been shown to bind to mammalian IREs (94). The sequence
motif DLVIDH-IQV implicated in RNA binding of IRP (95) is nearly
conserved in TbACO (three conservative substitutions); however, no
sequence-specific binding of the mammalian IRE consensus RNA sequence
to recombinant purified TbACO could be detected.2 The
putative trypanosomal target RNA sequence may deviate, and thus a
regulatory role can only be addressed genetically. We have investigated
expression and regulation of one possible target, the trypanosomal
transferrin receptor, and found no change of its expression or
regulation in cells carrying a targeted deletion of TbACO
(96). Second, we have considered the possibility that TbACO serves as
cytoplasmic iron store. In fact, the IRP-related aconitase of L. pneumophila is the major iron-containing protein in that organism
(54). However, a calculation based on the iron uptake rate of
trypanosomes (97) showed that TbACO should contribute less than 10% to
the total iron content of proliferating slender bloodstream forms.
Given the abundance of cytoplasmic TbACO, particularly in the procyclic
stage, a metabolic function seems the most likely. In plant tissues,
cytoplasmic aconitase is developmentally regulated with a dramatic
increase during seed and pollen maturation and during germination,
reflecting glyoxalate cycle activity (reviewed in Ref. 19). Evidence
for a glyoxalate cycle in stationary promastigotes (probably metacyclic
forms) of the trypanosomatid Leishmania has been reported
(98, 99). Although key enzymes of the glyoxalate cycle have not been
detected in procyclic forms of T. brucei in culture,3 a functional
glyoxalate cycle may be operative and important at some later stage in
the insect vector, where utilization of storage lipids may compensate
for temporary shortage of nutrients. We are currently testing this
hypothesis by tsetse fly passage of TbACO knock out strains.
Citric acid cycle activities and certain respiratory chain activities
are turned on in the stumpy bloodstream stage of T. brucei
as a preadaptation to the tsetse midgut environment, where rapid
differentiation to the procyclic stage is essential for survival (5,
8). The developmental profile of TbACO expression fully accounts for
the previously reported changes of total aconitase activity (5, 7) and
parallels the developmental changes in energy metabolism in the
trypanosomal life cycle (1, 2). More than 30-fold developmental
regulation of TbACO contrasts with only a minor change of mRNA
abundance, indicating a translational or post-translational mechanism.
The only other citric acid cycle enzyme that has been cloned so far,
malate dehydrogenase, seems to be regulated in a similar fashion (100).
We anticipate that a common translational or post-translational
mechanism may coordinately up-regulate citric acid cycle activities
upon differentiation. Whereas numerous examples suggest a predominance
of regulation at the level of differential mRNA stability in
trypanosomatids (101, 102), only a handful of examples of translational
or post-translational regulation have been reported (103-107).
 |
ACKNOWLEDGEMENTS |
M. van den Bogaard and C. Modes contributed
to the subcellular localization and protein purification, respectively.
We thank P. Michels for the phosphoglycerate kinase antiserum; U. Goeringer for a partially purified mitochondrial vesicle fraction; P. Bastin and K. Gull for the BB2 hybridoma; G. Gerisch for -tubulin
antiserum; E. Vassella for a Northern filter; and H. Lauble and P. Overath for critical reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Bundesministerium für
Bildung, Wissenschaft, und Forschung Grant 0311092 (to M. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF127456, AF127457, and AF190556.
Present address: Bayer Yakuhin Ltd., Research Center Kyoto,
6-5-1-3 Kunimidai, Kizu-cho, Soraku-gun, Kyoto, 619-02, Japan.

To whom correspondence should be addressed: AG Molekulare
Zellbiologie, Institut für Molekularbiologie und Biochemie, FU Berlin, Hindenburgdamm 27, D-12203 Berlin, Germany. Tel.:
49-30-8445-3820; Fax: 49-30-8445-3840; E-mail:
boshart@ukbf.fu-berlin.de.
2
B. Fast and M. Boshart, unpublished data.
3
F. Opperdoes, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
IRP, iron-regulatory
protein;
IPTG, isopropyl-1-thio- -D-galactopyranoside;
IRE, iron-responsive element;
kb, kilobase pairs;
MES, 2-(N-morpholino)-ethanesulfonic acid;
NBT, nitro blue
tetrazolium;
PCF, procyclic forms;
PCR, polymerase chain reaction;
SS, short stumpy forms;
UTR, untranslated region;
bp, base pair;
DTT, dithiothreitol;
PAGE, polyacrylamide gel electrophoresis;
PBS, phosphate-buffered saline;
RACE, rapid amplification of cDNA ends;
NTA, nitrilotriacetic acid.
 |
REFERENCES |
| 1.
|
Vickerman, K.
(1985)
Br. Med. Bull.
41,
105-114[Abstract/Free Full Text]
|
| 2.
|
Fairlamb, A. H.,
and Opperdoes, F. R.
(1986)
in
Carbohydrate Metabolism in Cultured Cells
(Morgan, M. J., ed)
, pp. 183-224, Plenum Publishing Corp., New York
|
| 3.
|
Opperdoes, F. R.
(1987)
Annu. Rev. Microbiol.
41,
127-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Clayton, C. E.,
and Michels, P.
(1996)
Parasitol. Today
12,
465-471[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Durieux, P. O.,
Schütz, P.,
Brun, R.,
and Köhler, P.
(1991)
Mol. Biochem. Parasitol.
45,
19-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Vickerman, K.
(1965)
Nature
208,
762-766[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Overath, P.,
Czichos, J.,
and Haas, C.
(1986)
Eur. J. Biochem.
160,
175-182[Medline]
[Order article via Infotrieve]
|
| 8.
|
Priest, J. W.,
and Hajduk, S. L.
(1994)
J. Bioenerg. Biomembr.
26,
179-191[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Reuner, B.,
Vassella, E.,
Yutzy, B.,
and Boshart, M.
(1997)
Mol. Biochem. Parasitol.
90,
269-280[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Vassella, E.,
Reuner, B.,
Yutzy, B.,
and Boshart, M.
(1997)
J. Cell Sci.
110,
2661-2671[Abstract]
|
| 11.
|
Brun, R.,
and Schonenberger, M.
(1981)
Z. Parasitenk.
66,
17-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Matthews, K. R.,
and Gull, K.
(1997)
J. Cell Sci.
110,
2609-2618[Abstract]
|
| 13.
|
Beinert, H.,
Kennedy, M. C.,
and Stout, C. D.
(1996)
Chem. Rev.
96,
2335-2373[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Kent, T. A.,
Dreyer, J. L.,
Kennedy, M. C.,
Huynh, B. H.,
Emptage, M. H.,
Beinert, H.,
and Munck, E.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
1096-1100[Abstract/Free Full Text]
|
| 15.
|
Theil, E. C.
(1994)
Biochem. J.
304,
1-11
|
| 16.
|
Rouault, T. A.,
Klausner, R. D.,
and Harford, J. B.
(1996)
Translational Control
, pp. 335-362, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 17.
|
Kühn, L. C.,
and Hentze, M. W.
(1992)
J. Inorg. Biochem.
47,
183-195[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Hentze, M. W.,
and Kühn, L. C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8175-8182[Abstract/Free Full Text]
|
| 19.
|
Escher, C. L.,
and Widmer, F.
(1997)
Biol. Chem. Hoppe-Seyler
378,
803-813
|
| 20.
|
De Bellis, L.,
Hayashi, M.,
Nishimura, M.,
and Alpi, A.
(1995)
Planta
195,
464-468
|
| 21.
|
Hayashi, M.,
De Bellis, L.,
Alpi, A.,
and Nishimura, M.
(1995)
Plant Cell Physiol.
36,
669-680[Abstract/Free Full Text]
|
| 22.
|
Vassella, E.,
and Boshart, M.
(1996)
Mol. Biochem. Parasitol.
82,
91-105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Cross, G. A. M.
(1975)
Parasitology
71,
393-417[Medline]
[Order article via Infotrieve]
|
| 24.
|
Hirumi, H.,
and Hirumi, K.
(1989)
J. Parasitol.
75,
985-989[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Brun, R.,
and Schonenberger, M.
(1979)
Acta Trop.
36,
289-292[Medline]
[Order article via Infotrieve]
|
| 26.
|
Lanham, S. M.,
and Godfrey, D. G.
(1970)
Exp. Parasitol.
28,
521-534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Carruthers, V. B.,
van der Ploeg, L. H. T.,
and Cross, G. A. M.
(1993)
Nucleic Acids Res.
21,
2537-2538[Free Full Text]
|
| 28.
|
Wirtz, E.,
Hoek, M.,
and Cross, G. A. M.
(1998)
Nucleic Acids Res.
26,
4626-4634[Abstract/Free Full Text]
|
| 29.
|
Bastin, P.,
Bagherzadeh, A.,
Matthews, K. R.,
and Gull, K.
(1996)
Mol. Biochem. Parasitol.
77,
235-239[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Boshart, M.,
Weih, F.,
Nichols, M.,
and Schütz, G.
(1991)
Cell
66,
849-859[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Mizobuchi, M.,
and Frohman, L. A.
(1992)
BioTechniques
12,
350-354[Medline]
[Order article via Infotrieve]
|
| 32.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1987)
Current Protocols in Molecular Biology
, John Wiley & Sons, Inc., New York
|
| 33.
|
White, T. C.,
Rudenko, G.,
and Borst, P.
(1986)
Nucleic Acids Res.
14,
9471-9489[Abstract/Free Full Text]
|
| 34.
|
Villarejo, M. R.,
and Zabin, I.
(1974)
J. Bacteriol.
120,
466-474[Abstract/Free Full Text]
|
| 35.
|
Murakami, K.,
and Yoshino, M.
(1997)
Biochem. Mol. Biol. Int.
41,
481-486[Medline]
[Order article via Infotrieve]
|
| 36.
|
Kennedy, M. C.,
Emptage, M. H.,
Dreyer, J. L.,
and Beinert, H.
(1983)
J. Biol. Chem.
258,
11098-11105[Abstract/Free Full Text]
|
| 37.
|
Henson, C. P.,
and Cleland, W. W.
(1967)
J. Biol. Chem.
242,
3833-3838[Abstract/Free Full Text]
|
| 38.
|
Hanes, C. S.
(1932)
Biochem. J.
26,
1406-1421
|
| 39.
|
Olmsted, J. B.
(1981)
J. Biol. Chem.
256,
11955-11957[Abstract/Free Full Text]
|
| 40.
|
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354[Abstract/Free Full Text]
|
| 41.
|
Häusler, T.,
Stierhof, Y.-D.,
Wirtz, E.,
and Clayton, C.
(1996)
J. Cell Biol.
132,
311-324[Abstract/Free Full Text]
|
| 42.
|
Vassella, E.,
Straesser, K.,
and Boshart, M.
(1997)
Mol. Biochem. Parasitol.
90,
381-385[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acids Res.
22,
4673-4680[Abstract/Free Full Text]
|
| 44.
|
Strimmer, K.,
and von Haeseler, A.
(1996)
Mol. Biol. Evol.
13,
964-969
|
| 45.
|
Strimmer, K.,
Goldman, N.,
and Vonhaeseler, A.
(1997)
Mol. Biol. Evol.
14,
210-211
|
| 46.
|
Henikoff, S.,
and Henikoff, J. G.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10915-10919[Abstract/Free Full Text]
|
| 47.
|
Yang, Z.
(1994)
J. Mol. Evol.
39,
306-314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Kozak, M.
(1983)
Microbiol. Rev.
47,
1-45[Free Full Text]
|
| 49.
|
Robbins, A. H.,
and Stout, C. D.
(1989)
Proteins
5,
289-312[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Robbins, A. H.,
and Stout, C. D.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
3639-3643[Abstract/Free Full Text]
|
| 51.
|
Lauble, H.,
Kennedy, M. C.,
Beinert, H.,
and Stout, C. D.
(1992)
Biochemistry
31,
2735-2748[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Zheng, L.,
Kennedy, M. C.,
Beinert, H.,
and Zalkin, H.
(1992)
J. Biol. Chem.
267,
7895-7903[Abstract/Free Full Text]
|
| 53.
|
Frishman, D.,
and Hentze, M. W.
(1996)
Eur. J. Biochem.
239,
197-200[Medline]
[Order article via Infotrieve]
|
| 54.
|
Mengaud, J. M.,
and Horwitz, M. A.
(1993)
J. Bacteriol.
175,
5666-5676[Abstract/Free Full Text]
|
| 55.
|
Purnelle, B.,
Coster, F.,
and Goffeau, A.
(1994)
Yeast
10,
1235-1249[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Sogin, M. L.
(1991)
Curr. Opin. Gen. & Dev.
1,
457-463[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Gruer, M. J.,
Artymiuk, P. J.,
and Guest, J. R.
(1997)
Trends Biochem. Sci.
22,
3-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Irvin, S. D.,
and Bhattacharjee, J. K.
(1998)
J. Mol. Evol.
46,
401-408[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Gray, M. W.,
Burger, G.,
and Lang, F.
(1998)
Science
283,
1476-1481[Abstract/Free Full Text]
|
| 60.
|
Beinert, H.,
Emptage, M. H.,
Dreyer, J. L.,
Scott, R. A.,
Hahn, J. E.,
Hodgson, K. O.,
and Thomson, A. J.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
393-396[Abstract/Free Full Text]
|
| 61.
|
Philpott, C. C.,
Haile, D.,
Rouault, T. A.,
and Klausner, R. D.
(1993)
J. Biol. Chem.
268,
17655-17658[Abstract/Free Full Text]
|
| 62.
|
Hirling, H.,
Henderson, B. R.,
and Kühn, L. C.
(1994)
EMBO J.
13,
453-461[Medline]
[Order article via Infotrieve]
|
| 63.
|
Kennedy, M. C.,
Mende-Mueller, L.,
Blondin, G. A.,
and Beinert, H.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
11730-11734[Abstract/Free Full Text]
|
| 64.
|
Verniquet, F.,
Gaillard, J.,
Neuburger, M.,
and Douce, R.
(1991)
Biochem. J.
276,
643-648
|
| 65.
|
Pickworth Glusker, J.
(1971)
Enzymes
5,
413-439
|
| 66.
|
Lauble, H.,
and Stout, C. D.
(1995)
Proteins
22,
1-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 67.
|
Harris, M. E.,
Moore, D. R.,
and Hajduk, S. L.
(1990)
J. Biol. Chem.
265,
11368-11376[Abstract/Free Full Text]
|
| 68.
|
Schulz, I.
(1990)
Methods Enzymol.
192,
280-300[Medline]
[Order article via Infotrieve]
|
| 69.
|
Sommer, J. M.,
Cheng, Q.-L.,
Keller, G.-A.,
and Wang, C. C.
(1992)
Mol. Biol. Cell
3,
749-759[Abstract]
|
| 70.
|
Zhang, J. W.,
Luckey, C.,
and Lazarow, P. B.
(1993)
Mol. Biol. Cell
4,
1351-1359[Abstract]
|
| 71.
|
Hentze, M. W.
(1996)
Trends Biochem. Sci.
21,
282-283[CrossRef][Medline]
[Order article via Infotrieve]
|
| 72.
|
Rouault, T. A.,
and Klausner, R. D.
(1996)
Trends Biochem. Sci.
21,
174-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 73.
|
Muckenthaler, M.,
Gunkel, N.,
Frishman, D.,
Cyrklaff, A.,
Tomancak, P.,
and Hentze, M. W.
(1998)
Eur. J. Biochem.
254,
230-237[Medline]
[Order article via Infotrieve]
|
| 74.
|
Brouquisse, R.,
Nishimura, M.,
Gaillard, J.,
and Douce, R.
(1987)
Plant Physiol. (Bethesda)
84,
1402-1407[Abstract/Free Full Text]
|
| 75.
|
Courtois Verniquet, F.,
and Douce, R.
(1993)
Biochem. J.
294,
103-107
|
| 76.
|
De Bellis, L.,
Tsugeki, R.,
Alpi, A.,
and Nishimura, M.
(1993)
Physiol. Plant.
88,
485-492[CrossRef]
|
| 77.
|
Jordanov, J.,
Courtois-Verniquet, F.,
Neuburger, M.,
and Douce, R.
(1992)
J. Biol. Chem.
267,
16775-16778[Abstract/Free Full Text]
|
| 78.
|
Peyret, P.,
Perez, P.,
and Alric, M.
(1995)
J. Biol. Chem.
270,
8131-8137[Abstract/Free Full Text]
|
| 79.
|
Zhou, Y. H.,
and Ragan, M. A.
(1995)
Plant Mol. Biol.
28,
635-646[CrossRef][Medline]
[Order article via Infotrieve]
|
| 80.
|
Mewes, H. W.,
Albermann, K.,
Bahr, M.,
Frishman, D.,
Gleissner, A.,
Hani, J.,
Heumann, K.,
Kleine, K.,
Maierl, A.,
Oliver, S. G.,
Pfeiffer, F.,
and Zollner, A.
(1997)
Nature
387 (suppl.),
7-8[Medline]
[Order article via Infotrieve]
|
| 81.
|
Gangloff, S. P.,
Marguet, D.,
and Lauquin, G. J. M.
(1990)
Mol. Cell. Biol.
10,
3551-3561[Abstract/Free Full Text]
|
| 82.
|
Danpure, C. J.
(1995)
Trends Cell Biol.
5,
230-238[CrossRef][Medline]
[Order article via Infotrieve]
|
| 83.
|
Clayton, C.,
Hausler, T.,
and Blattner, J.
(1995)
Microbiol. Rev.
59,
325-344[Abstract/Free Full Text]
|
| 84.
|
Priest, J. W.,
and Hajduk, S. L.
(1995)
Biochim. Biophys. Acta
1269,
201-204[Medline]
[Order article via Infotrieve]
|
| 85.
|
Hauser, R.,
Pypaert, M.,
Häusler, T.,
Horn, E. K.,
and Schneider, A.
(1996)
J. Cell Sci.
109,
517-523[Abstract]
|
| 86.
|
Priest, J. W.,
and Hajduk, S. L.
(1996)
J. Biol. Chem.
271,
20060-20069[Abstract/Free Full Text]
|
| 87.
|
Häusler, T.,
Stierhof, Y. D.,
Blattner, J.,
and Clayton, C.
(1997)
Eur. J. Cell Biol.
73,
240-251[Medline]
[Order article via Infotrieve]
|
| 88.
|
Priest, J. W.,
Wood, Z. A.,
and Hajduk, S. L.
(1993)
Biochim. Biophys. Acta
1144,
229-231[Medline]
[Order article via Infotrieve]
|
| 89.
|
Stein, I.,
Peleg, Y.,
Even-Ram, S.,
and Pines, O.
(1994)
Mol. Cell. Biol.
14,
4770-4778[Abstract/Free Full Text]
|
| 90.
|
Jackman, S. A.,
Hough, D. W.,
Stevenson, D. J.,
and Opperdoes, F. R.
(1990)
Eur. J. Biochem.
193,
91-95[Medline]
[Order article via Infotrieve]
|
| 91.
|
Else, A. J.,
Hough, D. W.,
and Danson, M. J.
(1993)
Eur. J. Biochem.
212,
423-429[Medline]
[Order article via Infotrieve]
|
| 92.
|
Else, A. J.,
Clarke, J. F.,
Willis, A.,
Jackman, S. A.,
Hough, D. W.,
and Danson, M. J.
(1994)
Mol. Biochem. Parasitol.
64,
233-239[CrossRef][Medline]
[Order article via Infotrieve]
|
| 93.
|
Tyler, K. M.,
Matthews, K. R.,
and Gull, K.
(1997)
Proc. R. Soc. Lond. Ser. B Biol. Sci.
264,
1481-1490[Medline]
[Order article via Infotrieve]
|
| 94.
|
Alén, C.,
and Sonenshein, A. L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
10412-10417[Abstract/Free Full Text]
|
| 95.
|
Basilion, J. P.,
Rouault, T. A.,
Massinople, C. M.,
Klausner, R. D.,
and Burgess, W. H.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
574-578[Abstract/Free Full Text]
|
| 96.
|
Fast, B.,
Krempa, K.,
Boshart, M.,
and Steverding, D.
(1999)
Biochem. J.
342,
691-696
|
| 97.
|
Steverding, D.
(1998)
Parasitol. Res.
84,
59-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 98.
|
Keegan, F. P.,
and Blum, J. J.
(1993)
J. Euk. Microbiol.
40,
730-732[Medline]
[Order article via Infotrieve]
|
| 99.
|
Blum, J. J.
(1994)
J. Bioenerg. Biomembr.
26,
147-155[CrossRef][Medline]
[Order article via Infotrieve]
|
| 100.
|
Anderson, S. A.,
Carter, V.,
and Parsons, M.
(1998)
Exp. Parasitol.
89,
63-70[CrossRef][Medline]
[Order article via Infotrieve]
|
| 101.
|
Clayton, C.
(1992)
Prog. Nucleic Acids Res. Mol. Biol.
43,
37-66[Medline]
[Order article via Infotrieve]
|
| 102.
|
Vanhamme, L.,
and Pays, E.
(1995)
Microbiol. Rev.
59,
223-240[Abstract/Free Full Text]
|
| 103.
|
Torri, A. F.,
Bertrand, K. I.,
and Hajduk, S. L.
(1993)
Mol. Biochem. Parasitol.
57,
305-316[CrossRef][Medline]
[Order article via Infotrieve]
|
| 104.
|
Gale, M., Jr.,
Carter, V.,
and Parsons, M.
(1994)
J. Biol. Chem.
269,
31659-31665[Abstract/Free Full Text]
|
| 105.
|
Priest, J. W.,
and Hajduk, S. L.
(1994)
Mol. Biochem. Parasitol.
65,
291-304[CrossRef][Medline]
[Order article via Infotrieve]
|
| 106.
|
Schürch, N.,
Furger, A.,
Kurath, U.,
and Roditi, I.
(1997)
Mol. Biochem. Parasitol.
89,
109-121[CrossRef][Medline]
[Order article via Infotrieve]
|
| 107.
|
Hotz, H. R.,
Hartmann, C.,
Huober, K.,
Hug, M.,
and Clayton, C.
(1997)
Nucleic Acids Res.
25,
3017-3025[Abstract/Free Full Text]
|
| 108.
|
Rouault, T. A.,
Tang, C. K.,
Kaptain, S.,
Burgess, W. H.,
Haile, D. J.,
Samaniego, F.,
McBride, O. W.,
Harford, J. B.,
and Klausner, R. D.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
7958-7962[Abstract/Free Full Text]
|
| 109.
|
Zheng, L.,
Andrews, P. C.,
Hermodson, M. A.,
Dixon, J. E.,
and Zalkin, H.
(1990)
J. Biol. Chem.
265,
2814-2821[Abstract/Free Full Text]
|
| 110.
|
Bernstein, F. C.,
Koetzle, T. F.,
Williams, G. J.,
Meyer, E. F., Jr.,
Brice, M. D.,
Rodgers, J. R.,
Kennard, O.,
Shimanouchi, T.,
and Tasumi, M.
(1977)
Eur. J. Biochem.
80,
319-324[Medline]
[Order article via Infotrieve]
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Bandyopadhyay, S. G. Naik, I. P. O'Carroll, B.-H. Huynh, D. R. Dean, M. K. Johnson, and P. C. Dos Santos
A Proposed Role for the Azotobacter vinelandii NfuA Protein as an Intermediate Iron-Sulfur Cluster Carrier
J. Biol. Chem.,
May 16, 2008;
283(20):
14092 - 14099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Dos Santos, D. C. Johnson, B. E. Ragle, M.-C. Unciuleac, and D. R. Dean
Controlled Expression of nif and isc Iron-Sulfur Protein Maturation Components Reveals Target Specificity and Limited Functional Replacement between the Two Systems
J. Bacteriol.,
April 1, 2007;
189(7):
2854 - 2862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Johnson, M.-C. Unciuleac, and D. R. Dean
Controlled Expression and Functional Analysis of Iron-Sulfur Cluster Biosynthetic Components within Azotobacter vinelandii
J. Bacteriol.,
November 1, 2006;
188(21):
7551 - 7561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Smid, E. Horakova, V. Vilimova, I. Hrdy, R. Cammack, A. Horvath, J. Lukes, and J. Tachezy
Knock-downs of Iron-Sulfur Cluster Assembly Proteins IscS and IscU Down-regulate the Active Mitochondrion of Procyclic Trypanosoma brucei
J. Biol. Chem.,
September 29, 2006;
281(39):
28679 - 28686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Lind, F. Missirlis, O. Melefors, H. Uhrigshardt, K. Kirby, J. P. Phillips, K. Soderhall, and T. A. Rouault
Of Two Cytosolic Aconitases Expressed in Drosophila, Only One Functions as an Iron-regulatory Protein
J. Biol. Chem.,
July 7, 2006;
281(27):
18707 - 18714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. H. van Weelden, J. J. van Hellemond, F. R. Opperdoes, and A. G. M. Tielens
New Functions for Parts of the Krebs Cycle in Procyclic Trypanosoma brucei, a Cycle Not Operating as a Cycle
J. Biol. Chem.,
April 1, 2005;
280(13):
12451 - 12460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Riviere, S. W. H. van Weelden, P. Glass, P. Vegh, V. Coustou, M. Biran, J. J. van Hellemond, F. Bringaud, A. G. M. Tielens, and M. Boshart
Acetyl:Succinate CoA-transferase in Procyclic Trypanosoma brucei: GENE IDENTIFICATION AND ROLE IN CARBOHYDRATE METABOLISM
J. Biol. Chem.,
October 29, 2004;
279(44):
45337 - 45346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Drummelsmith, I. Girard, N. Trudel, and M. Ouellette
Differential Protein Expression Analysis of Leishmania major Reveals Novel Roles for Methionine Adenosyltransferase and S-Adenosylmethionine in Methotrexate Resistance
J. Biol. Chem.,
August 6, 2004;
279(32):
33273 - 33280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. H. van Weelden, B. Fast, A. Vogt, P. van der Meer, J. Saas, J. J. van Hellemond, A. G. M. Tielens, and M. Boshart
Procyclic Trypanosoma brucei Do Not Use Krebs Cycle Activity for Energy Generation
J. Biol. Chem.,
April 4, 2003;
278(15):
12854 - 12863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Gourley, S. B. Parker, B. J. Jones, K. B. Zumbrennen, and E. A. Leibold
Cytosolic Aconitase and Ferritin Are Regulated by Iron in Caenorhabditis elegans
J. Biol. Chem.,
January 24, 2003;
278(5):
3227 - 3234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Loyevsky, T. LaVaute, C. R. Allerson, R. Stearman, O. O. Kassim, S. Cooperman, V. R. Gordeuk, and T. A. Rouault
An IRP-like protein from Plasmodium falciparum binds to a mammalian iron-responsive element
Blood,
October 15, 2001;
98(8):
2555 - 2562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. K. Kubata, M. Duszenko, Z. Kabututu, M. Rawer, A. Szallies, K. Fujimori, T. Inui, T. Nozaki, K. Yamashita, T. Horii, et al.
Identification of a Novel Prostaglandin F2{alpha} Synthase in Trypanosoma brucei
J. Exp. Med.,
November 6, 2000;
192(9):
1327 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|